Intervention

Octreotide

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 15 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials15
Recruiting0
Common conditions22
Lead sponsors shown14
Advertisement

Clinical trials

15 shown
Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled StudyNCT05199038 · 2022-06-01
UNKNOWN
Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.NCT04353193 · 2020-06-01
UNKNOWN
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal VaricesNCT03624517 · 2018-09-19
TERMINATED
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast CancerNCT02294786 · 2014-12-17
TERMINATED
Effects of Glucagon Administration on Energy ExpenditureNCT02237053 · 2014-09-01
COMPLETED
Hemodynamic Effects of Terlipressin and High Dose OctreotideNCT02119884 · 2014-02-01
COMPLETED
Etiology, Assessment and Treatment of Post-gastric Bypass Severe HypoglycemiaNCT01865760 · 2013-06-01
COMPLETED
Investigation of the Effects of Obesity Surgery on Appetitive BehaviourNCT02010385 · 2013-02-01
COMPLETED
Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal MuscleNCT02305069 · 2009-10-01
COMPLETED
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)NCT00399893 · 2006-12-01
TERMINATED
Ghrelin Suppression by Octreotide in Prader-WilliNCT01613495 · 2005-08-01
UNKNOWN
A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity PatientsNCT00171613 · 2005-02-01
COMPLETED
The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal BleedNCT00534677 · 2004-05-01
COMPLETED
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related DiarrheaNCT00002252
COMPLETED
A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.NCT00002253
COMPLETED

Trial status mix

COMPLETED9
TERMINATED3
UNKNOWN3

Phase mix

NA7
PHASE46
PHASE11
PHASE21
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.